<DOC>
	<DOCNO>NCT01437826</DOCNO>
	<brief_summary>The trial aim evaluate efficacy multiagent antioxidant compound ( vitamin A , C , E , selenium zinc ) reduce incidence metachronous adenomas large bowel endoscopic polypectomy . This randomized study : 50 % reduction incidence metachronous adenoma expect patient allocate `` active '' compound ( intervention ) arm compare assigned placebo .</brief_summary>
	<brief_title>Antioxidant Supplement Reduction Metachronous Adenomas Large Bowel : Double Blind Randomized Trial</brief_title>
	<detailed_description>Adenomatous polyp ( adenoma ) benign lesion large bowel frequent people age 60 : one four least one adenoma . In time , adenoma could progress cancer . Even though small rate adenoma develop cancer almost 70-80 % colorectal cancer origin adenoma colorectal cancer one frequent malignant tumor western world . Several epidemiological study show subject low intake and/or low blood level selenium increase risk develop colorectal cancer .</detailed_description>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>age 2575 year least one histologically confirm adenoma endoscopically remove large bowel result polypfree colonrectum ( clean colon ) . polypectomy perform 6 month enrolment trial history Familial Adenomatous Polyposis inflammatory bowel disease adenoma invasive carcinoma ten adenomas large sessile adenoma ( 3 cm colorectal resection invasive cancer site lifethreatening and/or chronic heart , liver kidney disease current use vitamin calcium supplement mental disability</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>chemoprevention</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>metachronous adenoma</keyword>
	<keyword>randomize trial</keyword>
</DOC>